did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

We're the #1 textbook rental company. Let us show you why.

9780323010030

Psychotropic Drugs

by ;
  • ISBN13:

    9780323010030

  • ISBN10:

    0323010032

  • Edition: 3rd
  • Format: Paperback
  • Copyright: 2001-01-01
  • Publisher: Elsevier Science Health Science div
  • Purchase Benefits
  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $39.95

Summary

This new third edition of PSYCHOTROPIC DRUGS combines both fundamental aspects of clinical psychopharmacology and individual drug profiles for a complete psychopharmacologic nursing reference. Part One provides an overview of psychotropic treatment; describes drugs in terms of the disorders they treat; discusses contemporary issues; and presents lifespan considerations. In Part Two, nearly 100 commonly used drugs are profiled in detail and organized alphabetically for quick reference. Includes new chapters on pharmacologic principles and herbal therapies; new content on ethinic differences is highlighted throughout.

Table of Contents

PART ONE CLINICAL PSYCHOPHARMACOLOGY 1(2)
UNIT I Introduction to Psychotropic Drug Use 3(74)
Psychiatric Care and Contemporary Treatment
4(7)
Benchmarks in Psychiatric Care: The Road from Confinement to Community
5(4)
Contemporary Issues in Psychopharmacology
9(1)
Remarks
10(1)
Functional Neuroanatomy
11(26)
Richard A. Sugerman
Central Nervous System
12(9)
Peripheral Nervous System
21(4)
Supraspinal Motor Pathways
25(4)
Limbic Structures--``Limbic System''
29(2)
Chemical Pathways in the CNS
31(6)
The Pharmacokinetic Basis of Therapeutics
37(19)
Pharmacokinetic Principles
37(6)
Pharmacodynamic Principles
43(2)
Adverse Reactions and Drug Interactions
45(1)
Other Pharmacokinetic and Pharmacodynamic Considerations
45(6)
Pharmacokinetics and Aging
51(2)
Pharmacokinetics and Culture
53(3)
Neuropharmacology and Psychotropic Drugs
56(21)
Jonathan Leo
Richard A. Sugerman
Synaptic Transmission
57(1)
Membrane Receptors
58(3)
Neurotransmission
61(1)
Action and Synthesis of Neurotransmitters
61(9)
Neurotransmitters and Neurochemistry of Behavior
70(7)
UNIT II Drugs Used in the Treatment of Mental Disorders 77(288)
Schizophrenia and Other Psychoses
78(46)
Historical Considerations
78(1)
The Evolution of Diagnostic Considerations in Understanding Schizophrenia
79(4)
Biologic Explanations of Schizophrenia
83(3)
Antipsychotic Drugs
86(23)
Traditional Antipsychotic Drugs by Chemical Classification
109(7)
Remarks
116(8)
Mood Disorders
124(61)
Mood or Affective Disturbances
124(4)
Antidepressants
128(41)
Tricyclic and Heterocyclic Antidepressants
138(4)
Specific Tricyclic Antidepressants
142(1)
Selective Serotonin Reuptake Inhibitors
143(6)
Venlafaxine
149(1)
Bupropion
150(1)
Nefazodone
150(1)
Mirtazapine
151(1)
Monoamine Oxidase Inhibitors
152(7)
Specific Monoamine Oxidase Inhibitors
159(1)
Norepinephrine Reuptake Inhibitors
159(2)
Treatment Issues with Antidepressants
161(4)
Alternative Treatments for Depression
165(2)
Significant Issues Related to Women and Antidepressant Therapy
167(2)
Antimanic and Mood-Stabilizing Drugs: Lithium
169(16)
Alternative Antimanic and Mood-Stabilizing Drugs
176(9)
Anxiety Disorders
185(28)
Historical Considerations
185(1)
Diagnostic Considerations
185(5)
Generalized Anxiety Disorder
186(4)
Anxiolytic Medications
190(8)
Benzodiazepines
190(5)
Buspirone
195(2)
Venlafaxine
197(1)
Specific Anxiety Disorders
198(15)
Panic Disorder
198(3)
Phobic Disorders
201(3)
Obsessive-Compulsive Disorder
204(3)
Posttraumatic Stress Disorder
207(2)
Ethnicity and Cultural Issues in Anxiety
209(4)
Dementia and Delirium
213(33)
Dementia Syndromes
213(24)
Disease Definition
213(1)
Evaluation and Diagnosis
214(5)
Stages of Dementia
219(1)
Specific Dementia Syndromes
220(3)
Treatment of Dementia--Nonpharmacologic Approaches
223(2)
Treatment of Dementia--Pharmacologic Approaches
225(12)
Delirium
237(9)
General Principles of Treatment in Delirium
238(2)
Drugs to Treat Delirium
240(2)
Treatment Issues in Delirium
242(4)
Seizure Disorders
246(31)
Luis Bencomo
Epilepsy
246(3)
Commonly Prescribed Antiepileptic Drugs
249(19)
Phenytoin
249(10)
Phenobarbital
259(3)
Carbamazepine
262(3)
Valproic Acid and Derivatives
265(2)
Benzodiazepines: Diazepam, Lorazepam, Clonazepam
267(1)
Other Important Antiepileptic Drugs
268(9)
Ethosuximide
269(1)
Trimethadione
270(1)
Primidone
270(1)
Newer Antiepileptics
271(3)
Rarely Used Antiepileptics
274(3)
Insomnia and Other Sleep Disorders
277(29)
Historical Considerations
277(1)
Diagnostic Considerations
277(3)
Drugs Used to Treat Insomnia
280(18)
Benzodiazepines
283(8)
Nonbenzodiazepine Hypnotics: Zolpidem and Zaleplon
291(2)
Other Drugs Used to Treat Insomnia
293(3)
Discussion
296(1)
Nonpharmacologic Treatment Strategies for Insomnia
297(1)
Other Sleep Disorders
298(8)
Hypersomnia and Excessive Sleepiness
298(4)
Narcolepsy
302(1)
Parasomnias
303(1)
Comorbid Conditions
303(3)
Acute Psychoses and the Violent Patient
306(16)
Scope of the Problem
306(1)
The Clinical Approach
306(1)
Policies on Violence
306(1)
Diagnostic Considerations
307(3)
Drug Treatment
310(12)
Short-Term Treatment
310(6)
Long-Term Treatment
316(4)
Implications and Treatment Issues
320(2)
Alcoholism and Other Substance Use Disorders
322(25)
Epidemiology
322(2)
Genetic, Environmental, and Other Influences
324(3)
Diagnostic Considerations
327(2)
Drug Treatment
329(18)
Objectives
329(1)
Drugs Used to Treat Alcoholism
330(2)
Drugs Used to Treat Opioid Dependence and Abuse
332(4)
Stimulants: Cocaine, Amphetamines, and Other Stimulants
336(3)
Drugs Used to Treat Nicotine Dependence
339(4)
Drugs Used to Treat Cannabis (Marijuana) Dependence
343(1)
Drugs Used to Treat Abuse of Phencyclidine and Similar Agents
343(1)
Drugs Used to Treat Sedative-Hypnotic and Anxiolytic Abuse and Dependence
344(3)
Sexual Dysfunction
347(18)
Luis Bencomo
David G. Folks
Diagnostic Considerations
349(3)
General Evaluation and Treatment Principles
352(1)
Female Sexual Disorders
352(3)
Male Sexual Dysfunction
355(5)
Sexual Dysfunction Caused by Medication and Medical Disorders
360(5)
UNIT III Drug Issues Related to Psychopharmacology 365(102)
Drugs Used for Electroconvulsive Therapy
366(16)
History of ECT
366(2)
Modern Electroconvulsive Therapy
368(6)
How Electroconvulsive Therapy Works
374(1)
Drugs Used in Electroconvulsive Therapy
375(1)
Anticholinergics: Atropine and Glycopyrrolate
375(1)
Anesthetics: Methohexital and Propofol
376(1)
Muscle Relaxant: Succinylcholine
377(5)
Drugs of Abuse
382(17)
Leland Allen
Alcohol
382(7)
Amphetamines
389(1)
Cannabis
390(1)
Cocaine
390(2)
Hallucinogens
392(1)
Inhalants
392(1)
Opioids
392(3)
Phencyclidine
395(1)
Sedative-Hypnotics
396(2)
Remarks
398(1)
Drugs Used to Stimulate the Central Nervous System
399(21)
Stimulants
399(11)
Amphetamines
399(7)
Methylphenidate
406(3)
Pemoline
409(1)
Other Stimulants: Caffeine and Amphetamine-Like Anorectics
410(10)
Caffeine
410(3)
Phenylpropanolamine
413(2)
Other Anorectics
415(1)
Treatment Considerations
415(2)
Patient Education for Individuals Prescribed Stimulants
417(3)
Drugs Used to Treat Extrapyramidal Side Effects
420(28)
Norman L. Keltner
Elizabeth Woodman Taylor
Review of Parkinson's Disease
420(7)
Review of Extrapyramidal Side Effects
427(4)
Drugs Used to Treat Parkinson's Disease
431(3)
Anticholinergic (Antiparkinsonism) Agents
434(7)
Related Anticholinergic Drugs
441(1)
Patient Education Issues
442(1)
Issues in Anticholinergic Drug Administration
442(2)
Other Agents Used to Treat EPSEs
444(4)
Herbiceuticals in Psychiatry
448(19)
David G. Folks
Teri Gabel
The Herbal Market
448(4)
Herbs Used for Psychotropic Effects
452(5)
Principles of Use of Herbs in Psychiatric Conditions
457(10)
UNIT IV Developmental Issues Related to Psychotropic Drugs 467(64)
Psychopharmacology for Children
468(28)
Lawrence Scahill
Scope of the Problem
468(1)
General Principles
468(2)
Psychotropic Medications Used with Children
470(26)
Stimulants
470(4)
Antidepressants
474(2)
Tricyclic Antidepressants
476(2)
Selective Serotonin Reuptake Inhibitors
478(3)
Other Antidepressant Medications
481(1)
Antipsychotic Drugs
482(5)
Lithium
487(1)
Alpha-2 Adrenergic Agonists
488(1)
Other Agents Used in the Treatment of Children with Psychiatric Disorders
489(7)
Psychopharmacology for Adolescents
496(19)
Lawrence Scahill
Scope of the Problem
496(1)
General Principles of Adolescent Psychopharmacology
496(2)
Psychotropic Medications Used with Adolescents
498(17)
Stimulants
498(2)
Antidepressants
500(3)
Antipsychotics
503(3)
Lithium
506(2)
Other Drugs Used in the Treatment of Bipolar Disorder
508(1)
Drugs Used in the Treatment of Aggressive Behavior
509(2)
Tic Disorders
511(1)
Use of Combined Drug Therapies
511(4)
Psychopharmacology for Elderly Persons
515(16)
Scope of the Problem
515(2)
General Factors Pertinent to Psychotropic Drug Therapy
517(7)
Psychiatric Disturbances Prevalent in Late Life
524(7)
Mood Disorders
525(1)
Psychotic Disorders
526(5)
PART TWO PSYCHOTROPIC DRUG PROFILES 531

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program